Literature DB >> 11006284

The protein-tyrosine kinase fer associates with signaling complexes containing insulin receptor substrate-1 and phosphatidylinositol 3-kinase.

M Iwanishi1, M P Czech, A D Cherniack.   

Abstract

In a screen for 3T3-F442A adipocyte proteins that bind SH2 domains, we isolated a cDNA encoding Fer, a nonreceptor protein-tyrosine kinase of the Fes/Fps family that contains a functional SH2 domain. A truncated splicing variant, iFer, was also cloned. iFer is devoid of both the tyrosine kinase domain and a functional SH2 domain but displays a unique 42-residue C terminus and retains the ability to form oligomers with Fer. Expression of both Fer and iFer proteins are strikingly increased upon differentiation of 3T3-L1 fibroblasts to adipocytes. Platelet-derived growth factor treatment of the cultured adipocytes caused rapid tyrosine phosphorylation of Fer and its recruitment to complexes containing platelet-derived growth factor receptor and the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase. Insulin treatment of 3T3-L1 adipocytes stimulated association of Fer with complexes containing tyrosine phosphorylated IRS-1 and PI 3-kinase but did not stimulate tyrosine phosphorylation of Fer. PI 3-kinase activity in anti-Fer immunoprecipitates was also acutely activated by insulin treatment of cultured adipocytes. These data demonstrate the presence of Fer tyrosine kinase in insulin signaling complexes, suggesting a role of Fer in insulin action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006284     DOI: 10.1074/jbc.M006665200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB.

Authors:  Canhui Guo; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Amplified Ras-MAPK signal states correlate with accelerated EGFR internalization, cytostasis and delayed HER2 tumor onset in Fer-deficient model systems.

Authors:  W Sangrar; C Shi; G Mullins; D LeBrun; B Ingalls; P A Greer
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

3.  FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.

Authors:  Yanchun Zhang; Xuexue Xiong; Qi Zhu; Jiali Zhang; Shengmiao Chen; Yuetong Wang; Jian Cao; Li Chen; Linjun Hou; Xi Zhao; Piliang Hao; Jian Chen; Min Zhuang; Dake Li; Gaofeng Fan
Journal:  Elife       Date:  2022-05-12       Impact factor: 8.713

4.  The Fer tyrosine kinase is important for platelet-derived growth factor-BB-induced signal transducer and activator of transcription 3 (STAT3) protein phosphorylation, colony formation in soft agar, and tumor growth in vivo.

Authors:  Johan Lennartsson; Haisha Ma; Piotr Wardega; Karin Pelka; Ulla Engström; Carina Hellberg; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

5.  Fer kinase limits neutrophil chemotaxis toward end target chemoattractants.

Authors:  Maitham Khajah; Graciela Andonegui; Ronald Chan; Andrew W Craig; Peter A Greer; Donna-Marie McCafferty
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

Review 6.  The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins.

Authors:  Fumihiko Hakuno; Toshiaki Fukushima; Yosuke Yoneyama; Hiroyasu Kamei; Atsufumi Ozoe; Hidehito Yoshihara; Daisuke Yamanaka; Takashi Shibano; Meri Sone-Yonezawa; Bu-Chin Yu; Kazuhiro Chida; Shin-Ichiro Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-26       Impact factor: 5.555

7.  Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells.

Authors:  Philippe Nizard; Frédéric Ezan; Dominique Bonnier; Nolwenn Le Meur; Sophie Langouët; Georges Baffet; Yannick Arlot-Bonnemains; Nathalie Théret
Journal:  BMC Genomics       Date:  2014-12-23       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.